乙型肝炎病毒蛋白和绿色荧光蛋白的共表达研究

目的：构建增强型绿色荧光蛋白（EGFP）标记的乙型肝炎病毒（HBV）真核表达载体,并研究其在真核细胞和小鼠体内的共表达。方法：以质粒pBR322-HBVadr2．0和pCX-EGFP为基础,构建含有双拷贝HBV全基因组DNA和EGFP基因的真核表达载体pCX-EGFP-HBVadr2．0,分别转染真核细胞和小鼠肝组织,建立体外、体内表达系统,研究GFP和HBV基因的表达。结果：构建了真核表达载体pCX-EGFP-HBVadr2．0,EGFP和HBV病毒蛋白在体内和体外均可表达。结论：构建的pCX-EGFP-HBVadr2．0真核表达载体可以GFP作为HBV存在与否的报告基因,提高了培育检测转基因小鼠的效率,为转基因小鼠的制备及后续研究奠定了基础。     

绿色荧光蛋白基因研究进展

绿色荧光蛋白（ｇｒｅｅｎ ｆｌｕｏｒｅｓｃｅｎｔ ｐｒｏｔｅｉｎ,ＧＦＰ）基因是目前唯一在细胞内稳定表达,不需要任何反应底物及其它辅助因子,无种属,组织和位置特异性,其产物ＧＦＰ对细胞无毒性,且检测简单,结果真实可靠的新型报告基因,其特有的生物化学性质使其在细胞生物学和分子生物学领域有着广泛的应用前景。     

丙型肝炎病毒核心蛋白抑制乙型肝炎病毒转录的分子机理

为研究丙型肝炎病毒 (HCV)核心蛋白抑制乙型肝炎病毒 (HBV)表达的分子机理 ,从HCV和HBV共感染中国病人血清中分离了 5个含HCV 5′非编码区 ( 5′NCR)和核心区 (CR)cDNA序列的克隆 .序列比较和系统发育分析显示 :从共感染病例中分离的HCV序列与其它已发表的从单独HCV感染病例中分离的序列没有显著差异 .共转染实验证实采用从其中 1例共感染病人中分离的核心蛋白cDNA基因所表达的核心蛋白 ,可抑制HBV表面抗原 (HBsAg)和HBVe抗原 (HBeAg)的表达 ,缺失突变分析说明HCV核心蛋白的C端疏水区对这种抑制作用是必需的 ,报道基因产物分析进一步说明了HBVC启动子和增强子Ⅱ是HCV核心蛋白的效应靶序列之一 ,而HCV核心蛋白在肝细胞和非肝细胞中均对HBV和其他细胞和病毒的基因的转录起负调节作用 .因此 ,认为HCV核心蛋白是一种多功能的负调节因子 ,与HCV和HBV以及HCV与细胞之间的相互作用密切相关     

绿色荧光蛋白与 HCV 核心蛋白的融合及在大肠杆菌中的高效表达

利用基因工程重组技术获得了绿色荧光蛋白（ｇｆｐ）基因与ＨＣＶ核心蛋白基因的嵌合体,并在大肠杆菌中高效表达了４８ｋＤａ的融合蛋白,经Ｄｏｔ－ＥＬＩＳＡ和Ｗｅｓｔｅｒｎ ｂｌｏｔ免疫活性分析证实,融合蛋白仍具有ｃｏｒｅ抗原的三个免疫活性部位,同时用荧光显微镜观察并用荧光光度计测定了大肠直菌表达的融合蛋白的荧光光谱,结果证实,我们在大肠杆菌中表达的ＧＦＰ－ｃｏｒｅ融合蛋白既能发射易于检测的绿色荧光,又具     

乙型肝炎病毒急性感染小鼠模型的建立

采用高压水注射方法,通过尾静脉将具有复制能力的HBV质粒导入BABL/cJ小鼠体内,应用real-time PCR、ELISA、RIA、Southern Blot、Northern Blot,以及免疫组化等方法,检测小鼠病毒血症、血清和肝组织中HBV 抗原表达动态变化、肝组织中HBV转录和复制情况,以及小鼠免疫应答状况。结果HBV基因可以在小鼠体内表 达和复制,并诱导小鼠产生特异性免疫应答,其应答模式及HBV清除过程与人类的HBV急性感染类似。实验显 示高压注射具有复制能力的HBV质粒可以在小鼠体内建立HBV急性感染模型,这种模型可以用于HBV病毒 学、免疫学以及抗病毒药物筛选等方向的研究。     

红色荧光和绿色荧光转基因小鼠模型的建立

目的建立红色荧光和绿色荧光转基因小鼠,为活体荧光影像系统建立重要的实验动物模型。方法把DsRed-Express和EGFP基因插入chicken-βactin强启动子下游构建转基因载体,建立红色荧光和绿色荧光转基因C57BL/6J小鼠。PCR鉴定红色荧光和绿色荧光转基因小鼠的基因表型,活体荧光影像系统分析红色荧光和绿色荧光转基因小鼠,荧光显微镜检测红色荧光和绿色荧光转基因小鼠全身组织器官的组织形态。结果分别建立了3个系的红色荧光和3个系的绿色荧光转基因小鼠。活体荧光影像系统分析转基因小鼠分别呈现红色荧光和绿色荧光。经荧光显微镜观察,DsRed-Express转基因小鼠的红色荧光蛋白在多个组织器官中表达,尤其在胰腺、肝脏、肾脏和脾脏等器官表达量较高。EGFP转基因小鼠绿色荧光蛋白在全身各个组织器官中表达,尤其在胰腺、心脏、小肠、外周血细胞和脑组织等器官组织中表达量较高。结论DsRed-Express和EGFP基因在转基因小鼠中系统性高表达,成功建立了红色荧光和绿色荧光转基因小鼠。DsRed-Express和EGFP转基因小鼠将成为活体荧光影像系统的重要实验动物模型。     

乙型肝炎病毒急性感染小鼠模型的建立

采用高压水注射方法,通过尾静脉将具有复制能力的HBV质粒导入BABL/cJ小鼠体内,应用real-timePCR、ELISA、RIA、Southern Blot、Northern Blot,以及免疫组化等方法,检测小鼠病毒血症、血清和肝组织中HBV抗原表达动态变化、肝组织中HBV转录和复制情况,以及小鼠免疫应答状况.结果HBV基因可以在小鼠体内表达和复制,并诱导小鼠产生特异性免疫应答,其应答模式及HBV清除过程与人类的HBV急性感染类似.实验显示高压注射具有复制能力的HBV质粒可以在小鼠体内建立HBV急性感染模型,这种模型可以用于HBV病毒学、免疫学以及抗病毒药物筛选等方面的研究.     

乙型肝炎病毒全长PreS蛋白基因在酵母中的表达

应用直接提取法从武汉地区乙型肝炎病人患者阳性血清中提取HBV基因组,以此作为模板,用引物PCR方法获得全长preS基因,该片段的DNA大小1203bp-克隆到pUCm-T载体中,应用M13通用引物进行序列测定,与中国HBV标准株序列比较,证实基因型为Adr亚型。有24个核苷酸不同,preS基因包含3个起始密码ATG分别为preS1,preS2,和S的翻译起点。然后将preS基因克隆到毕赤酵母表达载体pPIC9K中,将Sal Ⅰ线性化的pPIC9K—preS质粒用电击法导入巴斯德一毕赤酵母GS115His中。通过MD—G418平板筛选和5‘‘‘‘‘‘‘‘AOXI和3’AOXI引物PCR鉴定获得稳定重组HBV全长严preS基因的His^ Mut^ 酵母工程菌株。此酵母菌株在合适的培养条件和甲醇诱导下高效表达产生全长preS蛋白并可分泌到培养液中,SDS—PAGE显示培养液中含有分子量约为48kDa的带;微孔ELISIA法证实表达并分泌到培养液中的preS蛋白能够与HBV抗体阳性血清发生特异性反应。     

Purification of green fluorescent protein using a two-intein system

A two-intein purification system was developed for the affinity purification of GFPmut3*, a mutant of green fluorescent protein. The GFPmut3* was sandwiched between two self-cleaving inteins. This approach avoided the loss of the target protein which may result from in vivo cleavage of a single intein tag. The presence of N- and C-terminal chitin-binding domains allowed the affinity purification by a single-affinity chitin column. After the fusion protein was expressed and immobilized on the affinity column, self-cleavage of the inteins was sequentially induced to release the GFPmut3*. The yield was 2.41 mg from 1 l of bacterial culture. Assays revealed that the purity was up to 98% of the total protein. The fluorescence and circular dichroism spectrum of GFPmut3* demonstrated that the purified protein retains the correctly folded structure and function.     

绿色荧光报告基因在细胞免疫检测中的应用

将丙肝病毒C E1区基因插入绿色荧光报告基因pEGFP-N1中,构建真核表达重组质粒pEGFP-N1-HCV/C E1。转染小鼠骨髓瘤细胞SP2/0,在荧光显微镜下观察绿色荧光融合蛋白的表达情况。结果在细胞浆中出现了绿色荧光,表明目的基因得到表达,再通过G418筛选后大量培养用作细胞毒实验的靶细胞,结果表明以EGFP报告基因作筛选标记制备的靶细胞完全可以满足细胞毒实验要求。     

乙型肝炎病毒X蛋白对细胞凋亡的影响存在剂量依赖性

乙型肝炎病毒(HBV)X蛋白(HBx)与HBV相关肝细胞肝癌(HCC)的发生和发展密切相关.深入研究HBx在HCC形成中的作用将为探索HBV致癌机制提供重要依据.HBx是多功能蛋白,其对细胞凋亡的影响至今仍存在分歧.许多研究表明,HBx既有促进细胞凋亡又有抑制细胞凋亡的功能,但原因不清楚.本研究中,将表达HBx的质粒短...     

Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins

A trans-packaging system for hepatitis C virus (HCV) subgenomic replicon RNAs was developed. HCV subgenomic replicon was efficiently encapsidated by the HCV structural proteins that were stably expressed in trans under the control of a mammalian promoter. Infectious HCV-like particles (HCV-LPs), established a single-round infection, were produced and released into culture medium in titers of up to 10³ focus forming units/ml. Expression of NS2 protein with structural proteins (core, E1, E2, and p7) was shown to be critical for the infectivity of HCV-LPs. Anti-CD81 treatment decreased the number of infected cells, suggesting that HCV-LPs infected cells in a CD81-dependent manner. The packaging cell line should be useful both for the production of single-round infectious HCV-LPs to elucidate the mechanisms of HCV assembly, particle formation and infection to host cells, and for the development of HCV replicon-based vaccines.     

乙肝病毒X蛋白结合蛋白最新研究进展

乙肝病毒X蛋白结合蛋白(HBXIP)是肝细胞癌变过程的一个关键因素,它能在动物肌肉组织和恶性肿瘤组织中过表达。近年来研究显示:HBXIP能与人体内多种蛋白结合。本文综述了HBXIP蛋白参与细胞凋亡与增殖、细胞周期进程、中心体复制、肿瘤细胞迁移等过程,以期为以HBXIP蛋白为靶标的新的抗乙肝病毒等药物设计提供基础。     

Subgenomic replicon derived from a cell line infected with the hepatitis C virus

Recently, cell culture systems have been established, where a hepatitis C virus (HCV) subgenomic replicon was efficiently replicated and maintained for a long period. To see whether a HCV sequence derived from HCV-infected cultured cell sequence can be used for the construction of a functional replicon, a HCV subgenomic RNA carrying a neomycin-resistant gene was constructed using the HCV genome RNA obtained from cultured cells infected with HCV. After transfection, G418-resistant Huh-7 cells were selected and subcloned. Finally, the production of HCV proteins and de novo synthesis of subgenomic RNA were confirmed in the selected cell clone, indicating that this subgenomic RNA replicated in cultured cells and functioned as a replicon. These results suggest that the HCV genome obtained from an in vitro HCV infection system with cultured cells can be used to develop a subgenomic replicon system with diverse HCV sequences.     

HBx-EGFP-TLM融合蛋白表达载体的构建、蛋白表达纯化及活性检测

乙型肝炎病毒X蛋白 (HBx) 具有广泛的转录激活作用,但是由于细胞类型和实验条件的差异,外源启动子介导的HBx瞬时表达水平常表现出不均一性,为其功能的研究带来困难。为了解决HBx研究过程中遇到的这些难题,利用PCR扩增获得HBx及含转导肽TLM的EGFP编码序列,经酶切后插入pGEX-4T-1原核表达载体,成功构建重组质粒pGEX-HBx-EGFP-TLM和pGEX-EGFP-TLM。重组质粒转化大肠杆菌BL21(DE3) 感受态细胞,融合蛋白经IPTG诱导表达,采用?KTATM Purifier 蛋白纯化系统纯化并进行SDS-PAGE和Western blotting分析,确定为目的蛋白。将纯化后的融合蛋白分别与AML12和SMMC-7721细胞共孵育,Western blotting和激光共聚焦显微镜检测证实TLM转导肽能够介导HBx-EGFP和EGFP进入细胞,同时进入细胞的HBx-EGFP-TLM能够发挥转录激活活性,为HBx功能的深入研究奠定了基础。     

珊瑚和海葵来源红荧光蛋白的研究和应用

绿色荧光蛋白作为标记蛋白和报告蛋白在生物学研究中应用越来越广。但在荧光共振能量转移(fluorescenceresonanceenergytransfer,FRET)等技术中存在一些缺陷,需要更大波长范围的荧光蛋白。最近研究发现了多种来源于珊瑚和海葵的红荧光蛋白,这些长波长的荧光蛋白对绿色荧光蛋白是一种很好的代替和补充,可以实现细胞内多荧光标记,提供更理想的FRET荧光对。经随机突变和定点突变等方法改建获得的红荧光蛋白变种显示出更高的荧光强度,成熟时间也更短。目前应用较多的是来源于香菇珊瑚(Discosomasp.)的红荧光蛋白DsRed。     

Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype

To clarify the mechanism underlying resistance to interferon (IFN) by the hepatitis C virus (HCV) in patients with chronic hepatitis, we attempted to develop an IFN-resistant HCV replicon from the IFN-sensitive 50-1 replicon established previously. By treating 50-1 replicon cells with a prolonged low-dose treatment of IFN-alpha and then transfecting the total RNA derived from the IFN-alpha-treated replicon cells, we successfully obtained four clones (named 1, 3, 4, and 5) of HCV replicon cells that survived against IFN-alpha (200 IU/ml). These cloned cells were further treated with IFN-alpha or IFN-beta (increased gradually to 2000 or 1000 IU/ml, respectively). This led to four replicon cell lines (alphaR series) possessing the IFN-alpha-resistant phenotype and four replicon cell lines (betaR series) possessing the IFN-beta-resistant phenotype. Furthermore, we obtained an additional replicon cell line (alphaRmix) possessing the IFN-alpha-resistant phenotype by two rounds of prolonged treatment with IFN-alpha and RNA transfection as mentioned above. Characterization of these obtained HCV replicon cell lines revealed that the betaR series were highly resistant to both IFN-alpha and IFN-beta, although the alphaR series containing alphaRmix were only partially resistant to both IFN-alpha and IFN-beta. Genetic analysis of these HCV replicons found one common amino acid substitution in the NS4B and several additional amino acid substitutions in the NS5A of the betaR series, suggesting that these genetic alterations are involved in the IFN resistance of these HCV replicons. These newly established HCV replicon cell lines possessing IFN-resistant phenotypes are the first useful tools for understanding the mechanisms by which HCV acquires IFN resistance in vivo.     

榆黄蘑中一种抗病毒蛋白的纯化及其抗TMV和HBV的活性

采用阴离子交换层析和凝胶层析方法从新鲜食用菌榆黄蘑(Plearotus citrinopileatus)中进行了抗病毒蛋白的纯化,结果获得了一个纯化蛋白YP46-46,经SDS-PAGE可确定其分子量为27.4kD.以半叶法在枯斑寄主心叶烟上检测该蛋白对烟草花叶病毒(TMV)的抑制率,发现有较好的抗TMV活性,其抑制TMV的中浓度为0.24μg/mL.同时以HepG2.2.2.15细胞株为模型,对所获得的蛋白进行体外抗乙型肝炎病毒效果的评价.结果表明该蛋白对HBsAg的50%抑制时的浓度为0.08μg/mL,但对HBeAg效果不大.